Video

June 13, 2016

One of the main source of distrust towards public health authorities is the suspect of hidden connections with the pharmaceutical industry, but, in case of a severe pandemic, an adequate supply of antivirals and vaccines is essential. ASSET asked Norman Begg, GSK Vice President, Head of Scientific Affairs and Public Health, Vaccines, what kind of agreements exist for Public Health Emergencies of International Concern (PHEIC) or of a pandemic, between big pharma and WHO. The answer for the two situations is not the same.

Tags: 

May 27, 2016

Susanna Esposito, professor of Paediatrics at the University of Milan, Italy and president of WAIDID (World Association for Infectious Diseases), thinks that families need more information about safety and efficacy of vaccines, in order to overcome their growing hesitancy towards them.

Communication is the key.

May 11, 2016

Albert Osterhaus, director of the Research Center for Emerging Infections and Zoonoses (RIZ) in Hannover, Germany, is also a vet and a strong promoter of the One Health movement, which aims to consider animals and humans together, as possible sources and vectors of emerging diseases. In his lab MERS-Cov was discovered, which has caused thousands of cases and hundreds of deaths so far, mainly in the Middle East and in Korea. He has studied a new strategy to counteract this disease, vaccinating the dromedary camels, which are the main source of human infections.

Tags: 

April 26, 2016

As it was proved during 2009 A(H1N1) pandemic, vaccinating pregnant women against flu is usually safe and can protect both mother and children. Vaccination against whooping cough is recommended as well, while vaccines with live virus, such as nasal spray flu vaccine, measles and rubella, should not be used in these cases. Thomas Breuer, GSK Senior Vice president, Chief Medical Officer, Vaccines, tells ASSET about a new approach to protect babies against a dangerous infection such as SRV (syncytial respiratory virus), by immunising mothers during pregnancy with a vaccine which is currently under study at GSK.

January 18, 2016

The European Union's Seventh Framework Programme for research cofunds ASSET project, a resource in case of infectious threats.
ASSET project provides public health authorities with resources, suggestions and tools that could help to draw and review pandemic and epidemic preparedness plans, both national and transnational - introducing Science-in-Society issues, such as those related to ethics and gender.
It makes available a qualified and diverse network of experts in disaster management, public health and risk communication.
A bridge between stakeholders, public health authorities and general public, also through social media in order to encourage listening, improve dialogue, facilitate mutual learning and enhance mobilization.
Just in case.

Tags: 

December 14, 2015

Created in 2000, GAVI is an international organisation - a global Vaccine Alliance, bringing together public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the world’s poorest countries. According to Seth Berkley, CEO of the GAVI Alliance, such an experience can be relevant also in preparedness and response to emerging infectious threats.

Topic: 

September 17, 2015

From August 30 to September 5, the “Ettore Majorana” Centre for Scientific Culture in Erice hosted the “Mathematical and Computational Epidemiology of Infectious diseases” international conference. Aim of this event was to illustrate the major areas of research in mathematical and computational modelling of the spread of infectious diseases, and the huge variety of tools and approaches that are currently employed.

June 3, 2015

As the health editor of a prominent UK newspaper like The GuardianSarah Boseley has often faced the challenge of communicating uncertainty when dealing with health issues. This is even harder in the case of infectious disease outbreaks, when not all the information is always available from the beginning. Nevertheless, media should keep on trying to explain the public that sometimes even scientists and public health authorities have to say: “We don’t know”.

Topic: 

May 29, 2015

An infectious diseases specialist in London, Geraldine O’Hara spent two months in Sierra Leone with Médecins sans Frontières last year, at the peak of the Ebola crisis. While working in an Ebola treatment centre, she was asked to share her experience on Radio 4, a national radio station in UK. We met her at the International Journalism Festival in Perugia, where she told us about how she learnt such a new job and how she realized that real-life stories might greatly improve science communication.

Pages

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence